☰

Mark G. Wahrenbrock, Ph.D. - Publications

Affiliations: 
2004 University of California, San Diego, La Jolla, CA 
Area:
Pathology
Tree Info Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Shao B, Wahrenbrock MG, Yao L, David T, Coughlin SR, Xia L, Varki A, McEver RP. Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome. Blood. 118: 4015-23. PMID 21860019 DOI: 10.1182/Blood-2011-07-368514  0.559
2006 Wahrenbrock MG, Varki A. Multiple hepatic receptors cooperate to eliminate secretory mucins aberrantly entering the bloodstream: are circulating cancer mucins the "tip of the iceberg"? Cancer Research. 66: 2433-41. PMID 16489050 DOI: 10.1158/0008-5472.Can-05-3851  0.53
2004 Wahrenbrock MG, Varki A. Multiple Hepatic Clearance Receptors Facilitate Elimination of Secretory Mucins that Can Enter the Bloodstream in Pathological States and Generate Platelet-Rich Microthrombi. Blood. 104: 805-805. DOI: 10.1182/Blood.V104.11.805.805  0.587
2003 Wahrenbrock M, Borsig L, Le D, Varki N, Varki A. Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas Journal of Clinical Investigation. 112: 853-862. PMID 12975470 DOI: 10.1172/Jci18882  0.562
2002 Ellies LG, Ditto D, Levy GG, Wahrenbrock M, Ginsburg D, Varki A, Le DT, Marth JD. Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proceedings of the National Academy of Sciences of the United States of America. 99: 10042-7. PMID 12097641 DOI: 10.1073/Pnas.142005099  0.471
Show low-probability matches.